2Xideas AG Has $2.07 Million Stock Holdings in Revvity Inc. $RVTY

2Xideas AG decreased its position in Revvity Inc. (NYSE:RVTY) by 75.3% during the second quarter, HoldingsChannel reports. The firm owned 21,421 shares of the company’s stock after selling 65,361 shares during the quarter. 2Xideas AG’s holdings in Revvity were worth $2,072,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. UMB Bank n.a. raised its holdings in Revvity by 138.8% in the 2nd quarter. UMB Bank n.a. now owns 406 shares of the company’s stock worth $39,000 after acquiring an additional 236 shares during the period. CVA Family Office LLC boosted its holdings in Revvity by 79.0% during the second quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after acquiring an additional 181 shares during the period. New Age Alpha Advisors LLC acquired a new stake in shares of Revvity in the first quarter valued at about $44,000. Caitong International Asset Management Co. Ltd grew its position in shares of Revvity by 25.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company’s stock valued at $73,000 after purchasing an additional 140 shares during the last quarter. Finally, Kilter Group LLC bought a new position in shares of Revvity in the second quarter worth about $80,000. 86.65% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on RVTY shares. Weiss Ratings restated a “sell (d)” rating on shares of Revvity in a research note on Monday, December 1st. Bank of America cut their price target on Revvity from $110.00 to $99.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Robert W. Baird increased their price objective on Revvity from $122.00 to $123.00 and gave the company an “outperform” rating in a research report on Tuesday, October 28th. Evercore ISI reaffirmed an “outperform” rating and set a $108.00 target price on shares of Revvity in a research report on Monday, October 27th. Finally, Guggenheim began coverage on shares of Revvity in a research note on Wednesday, October 15th. They set a “neutral” rating for the company. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $114.75.

Revvity Trading Down 1.1%

Shares of RVTY stock opened at $99.70 on Tuesday. The firm has a fifty day moving average of $95.32 and a 200-day moving average of $93.05. The stock has a market cap of $11.30 billion, a price-to-earnings ratio of 50.10, a P/E/G ratio of 3.33 and a beta of 1.06. Revvity Inc. has a 52-week low of $81.36 and a 52-week high of $128.29. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 1.75.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Monday, October 27th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.14 by $0.04. The firm had revenue of $698.95 million during the quarter, compared to analyst estimates of $699.75 million. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The company’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.28 earnings per share. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. On average, equities research analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity announced that its Board of Directors has approved a stock buyback plan on Monday, October 27th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 8.7% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 6th. Stockholders of record on Friday, January 16th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, January 16th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio is presently 14.07%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.